Journal article

Lymph-node-derived stem-like but not tumor-tissue-resident CD8 T cells fuel anticancer immunity

SKM Wijesinghe, L Rausch, SS Gabriel, G Galletti, M De Luca, L Qin, L Wen, C Tsui, K Man, L Heyden, T Mason, LD Newland, A Kueh, Y Liao, D Chisanga, J Swatler, E Voulaz, G Marulli, V Errico, A Losurdo Show all

Nature Immunology | Springer Science and Business Media LLC | Published : 2025

Abstract

CD8+ T cell-mediated tumor control and efficacy of immune checkpoint blockade (ICB) are associated with both precursors of exhausted T (TPEX) cells and tissue-resident memory T cells. Their relationships and relative contribution to tumor control, however, are insufficiently understood. Using single-cell RNA sequencing and genetic mouse models, we systematically dissected the heterogeneity and function of cytotoxic T cells in tumors and tumor-draining lymph nodes (tdLNs). We found that intratumoral TCF1+ TPEX cells and their progeny acquired a tissue-residency program that limits their contribution to tumor control and ICB response. By contrast, MYB-dependent stem-like TPEX cells residing in..

View full abstract